Life Imaging gets $3 million infusion

Article

Three-dimensional ultrasound developer Life Imaging Systems has received a $3 million (Canadian) private placement from a Canadian investment firm. The cash infusion is part of a total investment of $8 million made in Life by Sofinov, Societé

Three-dimensional ultrasound developer Life Imaging Systems has received a $3 million (Canadian) private placement from a Canadian investment firm. The cash infusion is part of a total investment of $8 million made in Life by Sofinov, Societé financière d’innovation, of Montreal, Quebec.

Life plans to use the money for product commercialization and market expansion purposes, according to the company. Life, of London, Ontario, recently assembled a marketing team and developed a new corporate identity. It plans to display its products at this year’s Radiological Society of North America meeting.

Life’s L3D family of products are targeted at ultrasound OEMs and enable users to assemble 3-D ultrasound images from 2-D scans.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.